PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97180421 |
Filing Date: 12/20/2021 |
Input Field |
Entered |
SERIAL NUMBER | 97180421 |
---|---|
MARK INFORMATION | |
*MARK | WE FOCUS ON THIS SO THEY CAN FOCUS ON THAT |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | WE FOCUS ON THIS SO THEY CAN FOCUS ON THAT |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Novavax, Inc. |
*MAILING ADDRESS | 21 Firstfield Road |
*CITY | Gaithersburg |
*STATE (Required for U.S. applicants) |
Maryland |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
20878 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 042 |
*IDENTIFICATION | pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, and vaccines, and clinical trials and post-market trials related to pharmaceuticals, biologics, and vaccines |
FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 11/01/2021 |
FIRST USE IN COMMERCE DATE | At least as early as 11/01/2021 |
SPECIMEN FILE NAME(S) | |
JPG FILE(S) | \\TICRS\EXPORT18\IMAGEOUT 18\971\804\97180421\xml1 \ APP0003.JPG |
ORIGINAL PDF FILE | SPE0-769317753-2021122001 2256065233_._WE_FOCUS_ON_ THIS_SO_THEY_CAN_FOCUS_ON _THAT_Specimen_Ad.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT 18\971\804\97180421\xml1\ APP0004.JPG |
SPECIMEN DESCRIPTION | vaccine advertisements |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
ATTORNEY INFORMATION | |
NAME | Brendan J. Hughes |
ATTORNEY DOCKET NUMBER | 305047-20000 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Cooley LLP |
STREET | 1299 Pennsylvania Avenue, NW, Suite 700 |
CITY | Washington |
STATE | District of Columbia |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 20004 |
PHONE | 202-842-7800 |
FAX | (202) 842-7899 |
EMAIL ADDRESS | trademarks@cooley.com |
OTHER APPOINTED ATTORNEY | Susan Piascik Christoff, Brian Focarino, Bobby A. Ghajar, Colette A. Ghazarian, Rebecca Givner-Forbes, Kelley B. Harrington, Shannan Higgins, Ariana G. Hiscott, Judd D. Lauter, John Paul Oleksiuk, Anne H. Peck, Marcus D. Peterson, Elizabeth F. Reinhardt, Elisa Rosen, Dina Roumiantseva, Jane van Benten, and Colleen Wellington-Caban |
CORRESPONDENCE INFORMATION | |
NAME | Brendan J. Hughes |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@cooley.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | bhughes@cooley.com; jlauter@cooley.com; glinker@cooley.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /John A. Herrmann III/ |
SIGNATORY'S NAME | John A. Herrmann, III |
SIGNATORY'S POSITION | Senior Vice President, General Counsel & Corporate Secretary |
SIGNATORY'S PHONE NUMBER | 202-842-7899 |
DATE SIGNED | 12/20/2021 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97180421 |
Filing Date: 12/20/2021 |
The applicant's current Correspondence Information: |
Brendan J. Hughes |
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@cooley.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): bhughes@cooley.com; jlauter@cooley.com; glinker@cooley.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|